Department of Health and Social Care (DHSC) has issued a medicine supply notification for Oxybutynin 5mg modified-release tablets.
MSN/2023/048
Tier 2 – medium impact
Date of issue 24th April 2023
Oxybutynin 5mg modified-release tablets are out of stock until w/c 1st May 2023.
Oxybutynin immediate release formulations (tablets and liquid) remain available and can support an uplift in demand, as can alternative anticholinergic agents.
A copy of this medicine supply notification, including further information for pharmacy teams, has been sent to all pharmacy NHS email addresses.
DHSC and NHSE/I have now launched an online Medicines Supply Tool, which provides up to date information about medicine supply issues. The contents of these MSNs can now be viewed on the Tool.
The Tool also details any changes to resupply dates and updates to the entries.
To access the Tool you will need an NHS email address. Once set up and logged in, you will be able to access it online.
New shortages not listed on the SPS website, can be reported using our shortage reporting to
The post Medicine Supply Notification: Oxybutynin 5mg modified-release tablets appeared first on PSNC Website.